Acceleration of the Healing Process and Myocardial Regeneration May Be Important as a Mechanism of Improvement of Cardiac Function and Remodeling by Postinfarction Granulocyte Colony–Stimulating Factor Treatment
暂无分享,去创建一个
M. Arai | G. Takemura | S. Minatoguchi | H. Fujiwara | Xue-hai Chen | Ningyuan Wang | Y. Uno | M. Koda | Yu Misao | Chuanjiang Lu | Koji Suzuki | K. Gotō | A. Komada | Tomoyuki Takahashi | K. Kosai | T. Fujiwara | Kazuko Goto
[1] A. Luttun,et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.
[2] R. Visse,et al. Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .
[3] G. Takemura,et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. , 1998, Circulation research.
[4] Y. Taniyama,et al. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. , 2000, Circulation.
[5] E. Creemers,et al. Matrix Metalloproteinase Inhibition After Myocardial Infarction: A New Approach to Prevent Heart Failure? , 2001, Circulation research.
[6] David M. Bodine,et al. Bone marrow cells regenerate infarcted myocardium , 2001, Nature.
[7] I. Weissman,et al. Little Evidence for Developmental Plasticity of Adult Hematopoietic Stem Cells , 2002, Science.
[8] M. Arai,et al. A novel anti‐diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits , 1999, British journal of pharmacology.
[9] Federica Limana,et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Isner,et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.
[11] I. Vargel,et al. Effects of Growth Factors on Doxorubicin-Induced Skin Necrosis: Documentation of Histomorphological Alterations and Early Treatment by GM-CSF and G-CSF , 2002, Annals of plastic surgery.
[12] A. Salama,et al. Matrix metalloproteinase‐9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G–CSF , 2002, Transfusion.
[13] Doris A Taylor,et al. Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree? , 2002, Circulation.
[14] H. Saito,et al. Granulocyte colony‐stimulating factor (G‐CSF)‐mediated signaling regulates type IV collagenase activity in head and neck cancer cells , 2001, International journal of cancer.
[15] P. Libby,et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. , 2000, The Journal of clinical investigation.
[16] Klaus Pfeffer,et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes , 2003, Nature.
[17] D. Schuschke,et al. The effect of severe burn injury on proinflammatory cytokines and leukocyte behavior: its modulation with granulocyte colony-stimulating factor. , 1999, Burns : journal of the International Society for Burn Injuries.
[18] J. Isner,et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] W. Krüger,et al. A randomized comparison of once versus twice daily recombinant human granulocyte colony‐stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation , 2000, British journal of haematology.